Klaim key facts
- Developer of a healthcare claim payment acceleration platform designed for improving cash flow efficiency.
- It has raised $113.6M; the latest was Later Stage VC in Oct 2025.
- Notable investors include Techstars, Hub71, Mohammed Bin Rashid Innovation Fund, Cedar Mundi Ventures, Knuru Capital — 16 tracked in total.
- Status: Privately Held (backing).
Who backs Klaim
16+Membership and data by Private Market View
- ·The complete investor list: 16 names
- ·Watch Klaim: the Monday email on marks, rounds and moves
Klaim funding rounds
No funding rounds for Klaim are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Klaim investors
16 investors are on record for Klaim, including Techstars, Hub71, Mohammed Bin Rashid Innovation Fund and Cedar Mundi Ventures.
About Klaim
Developer of a healthcare claim payment acceleration platform designed for improving cash flow efficiency. The company's platform facilitates rapid reimbursement processing by purchasing submitted claims and disbursing payments, eliminating delays associated with traditional insurance settlements, enabling healthcare providers to stabilize revenue cycles, reduce administrative burdens, and enhance operational liquidity without requiring loans or credit assessments.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2019
- Employees
- 49
- Website
- klaim.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Klaim doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.